Ardan and GI Partners take co-control of Clinical ink in recapitalization
Winston-Salem eCOA and connected device developer Clinical ink gets new equity from Ardan Equity and GI Partners, which will share control of the company.
Most recent deal Monday, October 19, 2026.
Winston-Salem eCOA and connected device developer Clinical ink gets new equity from Ardan Equity and GI Partners, which will share control of the company.
Montreal-based Otodata, a remote tank monitoring and vehicle tracking provider, has taken on GI Partners as its majority investor.
Headquartered in Knoxville, the company provides janitorial, facilities-management and groundskeeping services to K-12 districts and higher education customers in more than 30 states.
GI Partners has closed its acquisition of Charles River Laboratories' CDMO and Cell Solutions businesses, which now operate as standalone Rose BioSolutions.